A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 464,199 shares of MRK stock, worth $46 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
464,199
Previous 442,293 4.95%
Holding current value
$46 Million
Previous $54.8 Million 3.73%
% of portfolio
0.18%
Previous 0.2%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$111.15 - $128.97 $2.43 Million - $2.83 Million
21,906 Added 4.95%
464,199 $52.7 Million
Q2 2024

Jul 26, 2024

BUY
$123.8 - $132.96 $956,107 - $1.03 Million
7,723 Added 1.78%
442,293 $54.8 Million
Q1 2024

Apr 24, 2024

SELL
$113.24 - $131.95 $1.89 Million - $2.21 Million
-16,732 Reduced 3.71%
434,570 $57.3 Million
Q4 2023

Feb 09, 2024

SELL
$100.18 - $109.02 $751,049 - $817,322
-7,497 Reduced 1.63%
451,302 $49.2 Million
Q3 2023

Oct 24, 2023

SELL
$102.95 - $114.33 $2.08 Million - $2.31 Million
-20,202 Reduced 4.22%
458,799 $47.2 Million
Q2 2023

Jul 13, 2023

BUY
$108.61 - $118.38 $13,033 - $14,205
120 Added 0.03%
479,001 $55.3 Million
Q1 2023

May 11, 2023

BUY
$102.94 - $114.86 $32,323 - $36,066
314 Added 0.07%
478,881 $50.9 Million
Q4 2022

Feb 08, 2023

BUY
$87.44 - $112.11 $2.76 Million - $3.54 Million
31,619 Added 7.07%
478,567 $53.1 Million
Q3 2022

Oct 17, 2022

BUY
$84.53 - $94.96 $272,355 - $305,961
3,222 Added 0.73%
446,948 $38.5 Million
Q2 2022

Jul 13, 2022

BUY
$83.49 - $94.64 $1.36 Million - $1.55 Million
16,344 Added 3.82%
443,726 $40.5 Million
Q1 2022

May 12, 2022

SELL
$73.51 - $82.4 $921,521 - $1.03 Million
-12,536 Reduced 2.85%
427,382 $35.1 Million
Q4 2021

Feb 03, 2022

BUY
$72.28 - $90.54 $783,948 - $981,996
10,846 Added 2.53%
439,918 $33.7 Million
Q3 2021

Nov 02, 2021

SELL
$71.68 - $78.83 $1.33 Million - $1.46 Million
-18,533 Reduced 4.14%
429,072 $32.2 Million
Q2 2021

Aug 10, 2021

SELL
$70.31 - $77.77 $1.02 Million - $1.13 Million
-14,566 Reduced 3.15%
447,605 $34.8 Million
Q1 2021

May 07, 2021

BUY
$68.86 - $81.11 $1.61 Million - $1.9 Million
23,446 Added 5.34%
462,171 $34 Million
Q4 2020

Feb 04, 2021

BUY
$71.77 - $79.65 $1.08 Million - $1.2 Million
15,072 Added 3.56%
438,725 $34.2 Million
Q3 2020

Oct 29, 2020

SELL
$73.18 - $82.95 $60,300 - $68,350
-824 Reduced 0.19%
423,653 $33.5 Million
Q2 2020

Jul 27, 2020

BUY
$70.42 - $80.13 $1.66 Million - $1.89 Million
23,599 Added 5.89%
424,477 $31.3 Million
Q1 2020

May 08, 2020

BUY
$63.36 - $87.82 $194,641 - $269,783
3,072 Added 0.77%
400,878 $29.4 Million
Q4 2019

Feb 04, 2020

BUY
$77.58 - $87.54 $4.33 Million - $4.89 Million
55,817 Added 16.32%
397,806 $34.5 Million
Q3 2019

Nov 06, 2019

BUY
$76.08 - $82.93 $206,861 - $225,486
2,719 Added 0.8%
341,989 $27.5 Million
Q3 2019

Oct 28, 2019

SELL
$76.08 - $82.93 $73,645 - $80,276
-968 Reduced 0.28%
339,270 $27.3 Million
Q2 2019

Aug 15, 2019

BUY
$69.84 - $81.59 $1.04 Million - $1.21 Million
14,870 Added 4.57%
340,238 $0
Q1 2019

May 08, 2019

SELL
$69.58 - $79.36 $1.45 Million - $1.65 Million
-20,842 Reduced 6.02%
325,368 $0
Q4 2018

Feb 05, 2019

BUY
$65.24 - $75.71 $1.11 Million - $1.28 Million
16,955 Added 5.15%
346,210 $25.2 Million
Q3 2018

Nov 02, 2018

SELL
$57.69 - $67.84 $353,755 - $415,994
-6,132 Reduced 1.83%
329,255 $0
Q2 2018

Aug 10, 2018

BUY
$50.83 - $59.72 $77,159 - $90,654
1,518 Added 0.45%
335,387 $0
Q1 2018

May 09, 2018

BUY
$50.96 - $59.23 $3.98 Million - $4.63 Million
78,159 Added 30.57%
333,869 $0
Q4 2017

Feb 22, 2018

BUY
$51.62 - $61.64 $1.26 Million - $1.51 Million
24,487 Added 10.59%
255,710 $0
Q3 2017

Nov 07, 2017

BUY
$58.67 - $63.13 $556,308 - $598,598
9,482 Added 4.28%
231,223 $14.8 Million
Q2 2017

Aug 08, 2017

BUY
N/A
221,741
221,741 $14.2 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.